Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Vivani Medical, Inc. (VANI)

Vivani Medical: Cortigent merger with ClearOne awaits final regulatory approval before closing

Neutral Impact 3 of 5 m&a Written later

Vivani Medical said its wholly owned subsidiary Cortigent will merge into a ClearOne subsidiary under a previously announced agreement. Closing still depends on final regulatory approval, and the parties expect it to occur shortly after that approval is received.

Key points

  • Vivani had anticipated the Transaction closing in October 2026.
  • Closing remains subject to receipt of final regulatory approval.
  • The filing gives no deal value, financial terms or regulatory timeline.

The filing

CompanyVivani Medical, Inc. (VANI)
Form8-K, current report
Filed with the SECOct 30, 2026, 4:30 PM ET
Accession number0001753926-26-002036

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 30, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.